Page last updated: 2024-10-20

spermine and Prostatic Neoplasms, Castration-Resistant

spermine has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, X1
Li, F1
Ye, F1
Guo, H1
Chen, W1
Jin, J1
Wang, Y1
Dai, P1
Shi, H1
Tao, H1
Dang, W1
Ding, Y1
Wang, M1
Jiang, H1
Chen, K1
Zhang, N1
Gao, D1
Zhang, Y1
Luo, C1

Other Studies

1 other study available for spermine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Spermine is a natural suppressor of AR signaling in castration-resistant prostate cancer.
    Cell reports, 2023, 07-25, Volume: 42, Issue:7

    Topics: Androgen Receptor Antagonists; Cell Line, Tumor; Humans; Male; Prostatic Neoplasms, Castration-Resis

2023